JP Patent

JP7336450B2 — （２ｓ）－ｎ－｛（１ｓ）－１－シアノ－２－［４－（３－メチル－２－オキソ－２，３－ジヒドロ－１，３－ベンゾオキサゾール－５－イル）フェニル］エチル｝－１，４－オキサゼパン－２－カルボキサミドを含む医薬組成物

Assigned to AstraZeneca AB · Expires 2023-08-31 · 3y expired

What this patent protects

Patent listed against Brinsupri.

Drugs covered by this patent

Patent Metadata

Patent number
JP7336450B2
Jurisdiction
JP
Classification
—
Expires
2023-08-31
Drug substance claim
No
Drug product claim
No
Assignee
AstraZeneca AB
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.